Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 374

1.

Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.

Millay DP, Maillet M, Roche JA, Sargent MA, McNally EM, Bloch RJ, Molkentin JD.

Am J Pathol. 2009 Nov;175(5):1817-23. doi: 10.2353/ajpath.2009.090107. Epub 2009 Oct 15.

2.

Defective membrane repair in dysferlin-deficient muscular dystrophy.

Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP.

Nature. 2003 May 8;423(6936):168-72.

PMID:
12736685
3.

Dysferlin and the plasma membrane repair in muscular dystrophy.

Bansal D, Campbell KP.

Trends Cell Biol. 2004 Apr;14(4):206-13. Review.

PMID:
15066638
4.

Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.

Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, Watkins SC, Cox GA, Brown RH Jr.

Hum Mol Genet. 2004 Sep 15;13(18):1999-2010. Epub 2004 Jul 14.

5.

Dysferlin protein analysis in limb-girdle muscular dystrophies.

Vainzof M, Anderson LV, McNally EM, Davis DB, Faulkner G, Valle G, Moreira ES, Pavanello RC, Passos-Bueno MR, Zatz M.

J Mol Neurosci. 2001 Aug;17(1):71-80.

PMID:
11665864
6.

Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.

Leriche-Guérin K, Anderson LV, Wrogemann K, Roy B, Goulet M, Tremblay JP.

Neuromuscul Disord. 2002 Feb;12(2):167-73.

PMID:
11738359
7.

Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.

Wenzel K, Carl M, Perrot A, Zabojszcza J, Assadi M, Ebeling M, Geier C, Robinson PN, Kress W, Osterziel KJ, Spuler S.

Hum Mutat. 2006 Jun;27(6):599-600.

PMID:
16705711
8.

Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.

Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, Nishi M, Takeshima H, Ma J.

J Biol Chem. 2009 Jun 5;284(23):15894-902. doi: 10.1074/jbc.M109.009589. Epub 2009 Apr 20.

9.

Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.

Cagliani R, Magri F, Toscano A, Merlini L, Fortunato F, Lamperti C, Rodolico C, Prelle A, Sironi M, Aguennouz M, Ciscato P, Uncini A, Moggio M, Bresolin N, Comi GP.

Hum Mutat. 2005 Sep;26(3):283.

PMID:
16100712
10.

Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.

Piccolo F, Moore SA, Ford GC, Campbell KP.

Ann Neurol. 2000 Dec;48(6):902-12.

PMID:
11117547
11.

Common pathological mechanisms in mouse models for muscular dystrophies.

Turk R, Sterrenburg E, van der Wees CG, de Meijer EJ, de Menezes RX, Groh S, Campbell KP, Noguchi S, van Ommen GJ, den Dunnen JT, 't Hoen PA.

FASEB J. 2006 Jan;20(1):127-9. Epub 2005 Nov 23.

12.

Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.

Matsuda C, Kameyama K, Tagawa K, Ogawa M, Suzuki A, Yamaji S, Okamoto H, Nishino I, Hayashi YK.

J Neuropathol Exp Neurol. 2005 Apr;64(4):334-40.

13.

Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.

Tagawa K, Ogawa M, Kawabe K, Yamanaka G, Matsumura T, Goto K, Nonaka I, Nishino I, Hayashi YK.

J Neurol Sci. 2003 Jul 15;211(1-2):23-8.

PMID:
12767493
14.

Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy.

Wenzel K, Zabojszcza J, Carl M, Taubert S, Lass A, Harris CL, Ho M, Schulz H, Hummel O, Hubner N, Osterziel KJ, Spuler S.

J Immunol. 2005 Nov 1;175(9):6219-25.

15.

Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity.

Demonbreun AR, Rossi AE, Alvarez MG, Swanson KE, Deveaux HK, Earley JU, Hadhazy M, Vohra R, Walter GA, Pytel P, McNally EM.

Am J Pathol. 2014 Jan;184(1):248-59. doi: 10.1016/j.ajpath.2013.09.009. Epub 2013 Oct 29.

16.

Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.

Rawat R, Cohen TV, Ampong B, Francia D, Henriques-Pons A, Hoffman EP, Nagaraju K.

Am J Pathol. 2010 Jun;176(6):2891-900. doi: 10.2353/ajpath.2010.090058. Epub 2010 Apr 22.

17.

Myoferlin, a candidate gene and potential modifier of muscular dystrophy.

Davis DB, Delmonte AJ, Ly CT, McNally EM.

Hum Mol Genet. 2000 Jan 22;9(2):217-26.

18.

In vivo and in vitro dysferlin expression in human muscle satellite cells.

De Luna N, Gallardo E, Illa I.

J Neuropathol Exp Neurol. 2004 Oct;63(10):1104-13.

19.

Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.

Flix B, de la Torre C, Castillo J, Casal C, Illa I, Gallardo E.

Int J Biochem Cell Biol. 2013 Aug;45(8):1927-38. doi: 10.1016/j.biocel.2013.06.007. Epub 2013 Jun 19.

PMID:
23792176
20.

Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.

Diers A, Carl M, Stoltenburg-Didinger G, Vorgerd M, Spuler S.

Neuromuscul Disord. 2007 Feb;17(2):157-62. Epub 2006 Nov 28.

PMID:
17129727
Items per page

Supplemental Content

Write to the Help Desk